Cargando…

Effects of hepatic arterial infusion chemotherapy in the treatment of hepatocellular carcinoma: A meta-analysis

BACKGROUND: The potential benefits and safety of hepatic arterial infusion chemotherapy (HAIC) for the treatment of patients with hepatocellular carcinoma (HCC) remains inconsistent. Therefore, we conducted this meta-analysis of evaluate the efficacy and safety of HAIC in the treatment of HCC. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Guan-Bao, Xiao, Chao-Wen, Zhao, Xin-Yang, Zhang, Jun, Li, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328911/ https://www.ncbi.nlm.nih.gov/pubmed/32590750 http://dx.doi.org/10.1097/MD.0000000000020745

Ejemplares similares

Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinoma
por: Tsai, Wei-Lun, et al.
Publicado: (2020)

TACE plus percutaneous chemotherapy-lipiodol treatment of unresectable pedunculated hepatocellular carcinoma
por: Huang, Dexiao, et al.
Publicado: (2017)

Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Li, Mu-xing, et al.
Publicado: (2015)

Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma: A meta-analysis
por: Xiao, Qi, et al.
Publicado: (2016)

Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma
por: Liu, Hui-Hui, et al.
Publicado: (2020)

Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis
por: An, Pei-Pei, et al.
Publicado: (2020)

Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma
por: Guo, Jian-Hai, et al.
Publicado: (2020)

Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma
por: Liu, Bao-Jiang, et al.
Publicado: (2020)

Nomogram for individualized prediction of recurrence after postoperative adjuvant TACE for hepatitis B virus-related hepatocellular carcinoma
por: Jiang, Jiang, et al.
Publicado: (2017)

Trans-catheter arterial chemoembolization plus Sorafenib, an unsuccessful therapy in the treatment of hepatocellular carcinoma?: A systematic review and meta-analysis
por: Zhang, Tao, et al.
Publicado: (2020)

The Relationship Between Serum Interleukin-6 and the Recurrence of Hepatitis B Virus Related Hepatocellular Carcinoma after Curative Resection
por: Sheng, Tao, et al.
Publicado: (2015)

Sorafenib Plus Hepatic Arterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
por: Peng, Peichun, et al.
Publicado: (2023)

Survival prediction model for postoperative hepatocellular carcinoma patients
por: Ren, Zhihui, et al.
Publicado: (2017)

The prognostic role of BORIS and SOCS3 in human hepatocellular carcinoma
por: Zhao, Rongce, et al.
Publicado: (2017)

Combination therapy: Meta-analysis of the effects of TACE and cryoablation on hepatocellular carcinoma
por: Yuan-Dong, Sun, et al.
Publicado: (2019)

Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: Transarterial Chemoembolization or Hepatic Resection?
por: Jianyong, Lei, et al.
Publicado: (2014)

Acupuncture treatment for chemotherapy-induced nausea and vomiting: A protocol for systematic review and meta-analysis
por: Huang, Yueping, et al.
Publicado: (2020)

Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma
por: Ma, Qiang, et al.
Publicado: (2016)

Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B
por: Wang, Christina, et al.
Publicado: (2016)

Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection
por: Yang, Wan-Ting, et al.
Publicado: (2016)

Diabetes mellitus increases the risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis C patients in China
por: Li, Xu, et al.
Publicado: (2017)

Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
por: Kim, Seung Up, et al.
Publicado: (2016)

The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network
por: Chang, Il-Chi, et al.
Publicado: (2016)

Combination treatment of transcatheter arterial chemoembolization, intensity-modulated radiotherapy, and sorafenib for hepatocellular carcinoma with macrovascular invasion
por: Yang, Dan, et al.
Publicado: (2023)

Preoperative γ-glutamyl transpeptidase to platelet ratio (GPR) is an independent prognostic factor for HBV-related hepatocellular carcinoma after curative hepatic resection
por: Wang, Wan-Li, et al.
Publicado: (2016)

Primary isolated hepatic tuberculosis mimicking small hepatocellular carcinoma: A case report
por: Yang, Caiwei, et al.
Publicado: (2020)

Clinical features of hepatitis B and C virus infections, with high α-fetoprotein levels but not hepatocellular carcinoma
por: Kim, Cha Young, et al.
Publicado: (2017)

Long non-coding RNA SNHG16 as a potential biomarker in hepatocellular carcinoma: A meta-analysis
por: Liu, Qiuli, et al.
Publicado: (2021)

Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma
por: Chen, Ching-Tso, et al.
Publicado: (2021)

Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in Japan
por: Nishikawa, Hiroki, et al.
Publicado: (2012)

Anterior approach combined with infrahepatic inferior vena cava clamping right hepatic resection for large hepatocellular carcinoma: A prospective randomized controlled trial
por: Zhou, Yan-Ming, et al.
Publicado: (2016)

Inflammation-nutrition scope predicts prognosis of early-stage hepatocellular carcinoma after curative resection
por: Zhu, Ying, et al.
Publicado: (2017)

Infiltrative Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Versus Hepatic Arterial Infusion Chemotherapy
por: An, Chao, et al.
Publicado: (2021)

Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular Carcinoma
por: Su, Shih-Chi, et al.
Publicado: (2015)

Risk factors of infection after transarterial chemoembolization for hepatocellular carcinoma: A protocol for systematic review and meta-analysis
por: Shi, Zhipeng, et al.
Publicado: (2021)

Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma
por: Zhong, Jian-Hong, et al.
Publicado: (2015)

Pre-S deletions of hepatitis B virus predict recurrence of hepatocellular carcinoma after curative resection
por: Li-Shuai, Qu, et al.
Publicado: (2017)

Thymalfasin, a promising adjuvant therapy in small hepatocellular carcinoma after liver resection
por: He, Chao, et al.
Publicado: (2017)

AFP-L3 for the diagnosis of early hepatocellular carcinoma: A meta-analysis
por: Zhou, Jian-Ming, et al.
Publicado: (2021)

The effectiveness of tivantinib for MET-high hepatocellular carcinoma: A protocol for meta analysis
por: Wang, Yubin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6j8d9p373b07lsgensqdopdlod